<p><h1>Global Drug-Eluting Balloon Market by Types, Applications, and Major Players, with Regional Growth Rate Analysis and Development Situation, from 2024 to 2031</h1></p><p><strong>Drug-Eluting Balloon Market Analysis and Latest Trends</strong></p>
<p><p>A Drug-Eluting Balloon (DEB) is a medical device used in cardiac and peripheral vascular interventions to deliver medications directly to the target site. It is a balloon catheter coated with an anti-proliferative drug, which is released during inflation at the site of the lesion. DEBs help in inhibiting restenosis, improving outcomes, and reducing the need for repeat procedures.</p><p>The Drug-Eluting Balloon Market is expected to grow at a CAGR of 6.8% during the forecast period. The market growth is driven by the increasing prevalence of cardiovascular diseases and peripheral arterial diseases, rising geriatric population, and advancements in technology. Furthermore, the shift towards minimally invasive procedures, higher adoption of DEBs due to reduced treatment costs and improved efficacy, and increasing awareness among patients and healthcare professionals are also contributing to the market growth.</p><p>Some of the latest trends in the Drug-Eluting Balloon Market include the development of novel DEB formulations, increasing research and development activities, strategic partnerships and collaborations among key players, and the introduction of advanced drug delivery technologies. Additionally, the rising demand for DEBs in emerging markets and the growing focus on personalized medicine are expected to further drive the market growth in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695011">https://www.reliableresearchreports.com/enquiry/request-sample/1695011</a></p>
<p>&nbsp;</p>
<p><strong>Drug-Eluting Balloon Major Market Players</strong></p>
<p><p>The Drug-Eluting Balloon Market is highly competitive and is dominated by key players such as Boston Scientific, Medtronic, Cook Medical, C.R. Bard, B. Braun, Eurocor GmbH, Blue Medical, Bayer, Aachen Resonance, and Acrostak.</p><p>Boston Scientific is a leading player in the market with a strong global presence. The company has been focusing on strategic acquisitions and collaborations to expand its product portfolio and gain a competitive edge. Medtronic is another key player that has a wide range of drug-eluting balloon products for various medical applications. The company has been investing in research and development to introduce innovative products in the market.</p><p>Cook Medical is known for its advanced drug-eluting balloon technologies and has been witnessing significant growth in the market. C.R. Bard is another prominent player with a diverse product portfolio and a strong presence in the market. B. Braun, Eurocor GmbH, Blue Medical, Bayer, Aachen Resonance, and Acrostak are also key players in the market that are focused on product innovation and expanding their market presence.</p><p>The global drug-eluting balloon market is expected to grow significantly in the coming years, driven by the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive treatment options. According to market research reports, the market size is estimated to reach $920 million by 2025, with a CAGR of 3.5% during the forecast period.</p><p>In terms of sales revenue, Boston Scientific reported $9.0 billion in sales in 2020, while Medtronic reported $29.7 billion in sales. Cook Medical, C.R. Bard, and B. Braun also reported strong sales revenue in the drug-eluting balloon market. These companies are expected to continue their growth trajectory in the market with their innovative product offerings and strategic initiatives.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Drug-Eluting Balloon Manufacturers?</strong></p>
<p><p>The global Drug-Eluting Balloon market is witnessing significant growth due to increasing prevalence of cardiovascular diseases and the rising adoption of minimally invasive procedures. The market is expected to continue growing at a steady pace over the coming years, fueled by advancements in technology, increasing geriatric population, and growing demand for effective treatment options. Key players in the market are focusing on research and development to introduce innovative products, further driving market growth. Overall, the Drug-Eluting Balloon market has a promising future outlook with ample opportunities for expansion and development.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695011">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695011</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Drug-Eluting Balloon Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Type I</li><li>Type II</li></ul></p>
<p><p>Drug-eluting balloon (DEB) market is categorized into two types: Type I and Type II. Type I market consists of stand-alone balloons used for percutaneous transluminal coronary angioplasty (PTCA). These balloons deliver drug directly to the vessel wall to prevent restenosis. On the other hand, Type II market involves DEBs utilized in conjunction with stents to achieve a synergistic effect in preventing restenosis. Both Type I and Type II markets cater to the growing demand for advanced treatment options in managing coronary artery disease.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1695011">https://www.reliableresearchreports.com/purchase/1695011</a></p>
<p>&nbsp;</p>
<p><strong>The Drug-Eluting Balloon Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Treatment of In-stent Restenosis (ISR)</li><li>Treatment of Small Vessel Disease (SVD)</li><li>Treatment of Bifurcation Stenoses</li><li>Treatment of Primary Coronary Artery Disease</li></ul></p>
<p><p>Drug-eluting balloons are used in the treatment of various coronary artery diseases, including in-stent restenosis, small vessel disease, bifurcation stenoses, and primary coronary artery disease. These balloons are coated with anti-proliferative drugs that inhibit cell growth and prevent re-narrowing of the artery post-treatment. They are effective in reducing the need for repeat interventions and improving outcomes for patients with these specific coronary artery conditions.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Drug-Eluting Balloon Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Drug-Eluting Balloon (DEB) market is expected to witness significant growth across various regions, with North America, Europe, and Asia-Pacific leading the market. North America and Europe are anticipated to dominate the market, with a market share of 35% and 30%, respectively. Meanwhile, Asia-Pacific, specifically China, is projected to show rapid growth, with a market share of 25%. The USA is also expected to contribute to the overall market growth with a 10% market share valuation.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1695011">https://www.reliableresearchreports.com/purchase/1695011</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695011">https://www.reliableresearchreports.com/enquiry/request-sample/1695011</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/provorikovar/Market-Research-Report-List-3/blob/main/airway-stent-lung-stent-market.md">Airway Stent / Lung Stent Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/conductive-polymer-aluminum-electrolytic-capacitor">Conductive Polymer Aluminum Electrolytic Capacitor Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/conductive-polymer-tantalum-solid-capacitor-market">Conductive Polymer Tantalum Solid Capacitor Market</a></p><p><a href="https://github.com/angelajermaine/Market-Research-Report-List-2/blob/main/medical-implant-market.md">Medical Implant Market</a></p><p><a href="https://github.com/CliffMedina6/Market-Research-Report-List-3/blob/main/gastrostomy-tube-market.md">Gastrostomy Tube Market</a></p></p>